Supramolecular Peptide Depots for Glucose-Responsive Glucagon Delivery

Area of Science:

• Biomaterials Science
• Diabetes Research
• Drug Delivery Systems

Background:

• Precise blood glucose control is crucial for managing type 1 diabetes and preventing complications.
• Current diabetes management strategies face challenges in achieving optimal glycemic control.

Purpose of the Study:

• To develop a glucose-responsive supramolecular peptide amphiphile (PA) material for controlled glucagon delivery.
• To investigate the self-assembly and glucose-binding properties of the PA-PBA system.
• To evaluate the in vitro and in vivo efficacy of the PA-PBA hydrogel for managing hypoglycemia.

Main Methods:

• Functionalization of peptide amphiphiles with phenylboronic acid (PBA).
• Characterization of hydrogel formation and properties using circular dichroism, zeta potential, and rheology.
• In vitro assessment of glucose-dependent glucagon release.
• In vivo evaluation in a type 1 diabetic mouse model to assess protection against insulin-induced hypoglycemia.

Main Results:

• The PA-PBA system self-assembles into nanofibrillar hydrogels responsive to physiological glucose levels.
• Hydrogel dissolution and glucagon release are inversely related to glucose concentration, accelerating under hypoglycemic conditions.
• In vivo studies demonstrated the platform's ability to restore blood glucose levels during insulin-induced hypoglycemia in mice.

Conclusions:

• Glucose-stabilized supramolecular peptide hydrogels offer a promising approach for responsive drug delivery.
• This platform demonstrates potential for improved glycemic control in type 1 diabetes.
• The PA-PBA system holds promise for managing diabetes and other metabolic disorders through tailored drug release.